The annual physical measures cholesterol and treats the cardiovascular story as complete. Half of first heart attacks occur in people whose standard lipid numbers looked acceptable and one of the reasons is that the standard panel never measures inflammation. The hs-CRP test, short for high-sensitivity C-reactive protein, is the measurement that fills that gap. It reads the low-grade inflammation inside arterial walls that contributes to plaque rupture, it predicts heart attacks and strokes independently of cholesterol and it usually costs less to run than the latte you bought on the way to the lab.
If your doctor has never ordered it, that is not neglect so much as habit. Standard panels were designed decades ago around cholesterol fractions. Our quarterly Biomarker Audit includes hs-CRP as a core marker because treating metabolic, hormonal and cardiovascular health as one system requires measuring all three lanes and inflammation is the lane the legacy panel skipped.
- hs-CRP measures low-grade systemic inflammation and predicts cardiovascular events independently of cholesterol.
- The usual interpretive bands are below 1.0 mg/L low, 1.0 to 3.0 mg/L intermediate and above 3.0 mg/L high, with values above 10 mg/L usually reflecting acute illness.
- Normal cholesterol with elevated hs-CRP is a real and common pattern that a standard panel misses entirely.
- Visceral fat, insulin resistance, poor sleep, gum disease and smoking are the common chronic drivers of an elevated value.
- The JUPITER trial showed that treating inflammation-bearing patients with normal LDL reduced events, which is why the result changes treatment rather than decorating a chart.
What the number actually represents
C-reactive protein is made by the liver in response to interleukin-6 and other inflammatory signals. A standard CRP test detects the large spikes that come with infection. The high-sensitivity version detects the small elevations that persist in otherwise healthy people and those small elevations are the signal. They reflect the inflammatory activity of atherosclerotic plaque itself and of the visceral fat that feeds it.
The interpretation bands are broad but useful. Below 1.0 mg/L sits in the low-risk band. Between 1.0 and 3.0 mg/L is intermediate. Above 3.0 mg/L is the high-risk band where the JUPITER trial found that a statin reduced events in people whose LDL was already normal, a finding that changed how medicine thinks about inflammation. Above 10 mg/L the test is usually telling you about a cold, a dental abscess or a sprained ankle rather than your arteries, so it gets repeated in two to three weeks once the acute process settles.
A single value is a snapshot. The clinically useful thing is the trend, which is why the marker repeats every 90 days in our protocol alongside everything that interprets it.
Why cholesterol alone undercounts your risk
Here is the reasoning that makes the test worth having. Atherosclerosis is not a plumbing problem caused by cholesterol sticking to passive pipes. It is an inflammatory disease in which cholesterol particles become trapped in the artery wall, oxidize and provoke an immune response. Both inputs matter. The ApoB number counts the particles delivering cholesterol into the wall. hs-CRP measures how aggressively the wall responds once they are there.
The original proof came from the late 1990s when Ridker and colleagues showed that baseline hs-CRP predicted future heart attacks among apparently healthy physicians and that the prediction held independent of cholesterol. Two adults can carry identical ApoB values and sit at opposite ends of the hs-CRP range and their five-year risks differ accordingly. One measurement without the other is half a conversation.
Reading hs-CRP alongside the rest of the panel
marker and meaning
| Marker | What it measures | What it adds |
|---|---|---|
| ApoB | Number of atherogenic particles | The raw supply of cholesterol entering artery walls |
| Lp(a) | Genetic lipoprotein variant | Lifelong inherited risk no diet changes |
| hs-CRP | Low-grade vascular inflammation | How inflammatory the environment inside the arteries is |
| HbA1c and fasting insulin | Glucose control and insulin load | The metabolic driver feeding both fat and inflammation |
| Blood pressure | Mechanical wall stress | The hemodynamic pressure that damages endothelium |
What raises hs-CRP and which causes matter most
An elevated hs-CRP raises a question before it names a diagnosis. The value responds to a long list of inputs and the clinical work is finding which one is yours.
Acute causes come first in time. Any infection, injury or recent vaccination can double or triple the value for days. This is why the marker is interpreted with your recent history and repeated if a cold or a dental procedure sits within the window.
Visceral fat is the most common chronic driver in otherwise healthy adults. Fat stored around the liver and organs is metabolically active and secretes inflammatory cytokines continuously. This is the reason an elevated hs-CRP and a stubborn waistband travel together so often and it is the reason the intervention is usually metabolic rather than cardiac.
Insulin resistance and poor sleep both hold inflammation up independently. A few nights of short sleep measurably raises inflammatory markers and untreated sleep apnea does the same chronically. Periodontal disease is a genuine and underappreciated contributor, which is why our intake asks about dental health. Smoking and heavy alcohol round out the lifestyle causes and autoimmune conditions fill the remainder of the differential.
You exercise, your weight is reasonable and your cholesterol is described as fine, but a parent had a heart attack in their fifties. That is exactly the profile where an hs-CRP and an ApoB add the most, because the inherited risk may be hiding in the lanes the standard panel never reads.
What a clinician does with the result
The result earns its place when it changes a decision. A low hs-CRP in a person with elevated ApoB tells the clinician the priority is bringing particle count down, so the conversation turns to statins, ezetimibe or the metabolic work that lowers ApoB. A high hs-CRP in a person with modest ApoB redirects the workup toward the source: visceral fat, sleep, gums, glucose. Both elevated together is the pattern that most argues for aggressive, early treatment, because particle supply and inflammatory environment are both adverse.
The JUPITER result deserves its own paragraph, because it is the clearest demonstration that the number changes management. In that trial, more than seventeen thousand adults with normal LDL cholesterol and elevated hs-CRP were randomized to rosuvastatin or placebo. The statin arm experienced roughly a forty-four percent reduction in major cardiovascular events. The population screened into that trial would have been called low risk by every standard panel and the inflammation marker was the only thing that found them.
How our membership reads inflammation
The Biomarker Audit we run every 90 days includes hs-CRP alongside ApoB, Lp(a), HbA1c, insulin markers, lipids and full hormone and thyroid panels, because those results interpret each other. An hs-CRP of 3.2 means something different in a person with an HbA1c of 5.9 and a fasting insulin at the top of its range than it does in a person with perfect metabolic numbers and a toothache last week. Reading the markers as one system is the whole clinical premise.
The audit is also longitudinal and inflammation is a marker where trends carry real information. A value that falls from 3.4 to 1.6 across two quarters after visceral fat loss and sleep repair tells you the intervention worked. A value that climbs despite weight loss sends the clinician looking for the source nobody found. Four panels a year make that kind of reading possible, which is the difference between measuring inflammation and glancing at it.
What it costs
The Cardiometabolic Optimization Membership is a flat $299 a month. The first charge at checkout is $598, one charge covering the first two months together: the clinical intake, the first comprehensive Biomarker Audit and the second month of care while your protocol is built. From month three it is $299 a month, month to month and you can cancel anytime after the initial commitment. Four full audits per year are inside that fee.
Medication is a separate charge, billed by your pharmacy at its own price with zero markup from us, no molecule upcharge and no dose-escalation fee. One flat fee for the doctor. Zero markup on the medicine. We make money when you get healthier, not when your dose gets stronger, which is why an abnormal result leads to a workup rather than a sales pitch.
Clinical care is delivered by licensed physicians of Beluga Health, P.A., an independent Florida professional corporation licensed to practice in all 50 states, working under GoodLife Health's clinical protocols. All labs run through the Beluga Health lab network and additional testing beyond the quarterly cadence is billed at pass-through cost. Where medication is indicated, only branded, FDA-approved options are prescribed and never compounded GLP-1 under any circumstance.
Who this test matters for most
If you have a family history of early heart disease, an hs-CRP belongs in your file regardless of what your cholesterol says. If you are a longevity optimizer who already tracks everything, the marker is the one most self-directed panels still miss. If you carry visceral weight you have struggled to move, the value explains part of why your cardiovascular risk is higher than your appearance suggests. And if your annual physical has passed you as healthy for a decade, the honest description is that it measured one lane of a three-lane system.
If you want the full panel read as one system rather than a stack of unrelated flags, start with the eligibility assessment. Two minutes, no card. A clinician reviews every application because not everyone is accepted.
FAQ
What does an hs-CRP test measure? High-sensitivity C-reactive protein, a blood marker of low-grade systemic inflammation. The assay detects the small elevations a standard CRP test misses and those elevations track with the inflammation inside arterial plaque that drives heart attacks and strokes.
What is a normal hs-CRP level? Below 1.0 mg/L is the low-risk band, 1.0 to 3.0 mg/L intermediate and above 3.0 mg/L high. Values above 10 mg/L usually reflect acute infection or injury and the test is repeated afterward. Trends across repeated panels matter more than any single value.
Can hs-CRP be high with normal cholesterol? Yes and it is one of the most useful things about the test. hs-CRP predicts events independently of LDL, which is why a normal lipid panel does not close the cardiovascular conversation.
What raises hs-CRP besides heart disease? Acute infection and injury raise it temporarily. Chronic drivers include visceral fat, insulin resistance, poor sleep, periodontal disease, smoking, heavy alcohol and autoimmune conditions. Visceral fat is the most common chronic cause in otherwise healthy adults.
How do I lower it? Visceral fat loss, regular exercise, sleep repair, smoking cessation and dental care all lower it with evidence behind them. Statins lower it alongside LDL and the JUPITER trial showed event reduction in inflammation-bearing patients with normal LDL. Finding the source comes first.
Is it part of a standard physical? Usually not, which is why the inflammation lane goes unmeasured in most annual panels. Our quarterly Biomarker Audit includes it alongside ApoB, Lp(a), HbA1c and insulin markers.
What does testing like this cost? The membership is a flat $299 a month after a $598 first charge covering the first two months together, with four comprehensive Biomarker Audits per year included. Medication, when indicated, is billed separately by your pharmacy at cost with zero markup.
Related Reading
- ApoB vs LDL: what really matters
- The Lp(a) test explained
- Cardiometabolic optimization: the definitive guide
- Biomarker audits vs standard blood tests
References
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (JUPITER, New England Journal of Medicine). 2008. pubmed.ncbi.nlm.nih.gov/18971472/
- C-Reactive Protein and the risk of future cardiovascular events (Ridker, New England Journal of Medicine). 1997. pubmed.ncbi.nlm.nih.gov/9202129/
- Testing for hs-CRP (American Heart Association). 2024. www.heart.org/en/health-topics/heart-attack/diagnosing-a-heart-attack/inflammation-and-heart-disease